Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-005110

Chief Development Officer sold 1,486 shares at $4.41 ($6,558)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
See Tai Sandi Chief Development Officer 2025-02-19 Sale −1,486 $4.41 $6,558 53,889 D: show line 1 in the form
Open-market sales · 1,486 sh · avg $4.41 · $6,558
Loading xslF345X05/form4-02212025_100238.xml…